19(T2)28z1xx TRAC T cell
/ Takeda, Memorial Sloan-Kettering Cancer Center
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
April 07, 2025
Study of 19(T2)28z1xx TRAC-Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Lymphoma
(clinicaltrials.gov)
- P1 | N=30 | Active, not recruiting | Sponsor: Memorial Sloan Kettering Cancer Center | Trial completion date: Feb 2025 ➔ Feb 2026 | Trial primary completion date: Feb 2025 ➔ Feb 2026
Trial completion date • Trial primary completion date • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Follicular Lymphoma • Hematological Malignancies • High-grade B-cell lymphoma • Large B Cell Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • Primary Mediastinal Large B-Cell Lymphoma • CD20
November 15, 2024
Study of 19(T2)28z1xx TRAC-Chimeric Antigen Receptor (CAR) T Cells in People with B-Cell Lymphoma
(clinicaltrials.gov)
- P1 | N=30 | Active, not recruiting | Sponsor: Memorial Sloan Kettering Cancer Center | Recruiting ➔ Active, not recruiting
Enrollment closed • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Follicular Lymphoma • Hematological Malignancies • High-grade B-cell lymphoma • Non-Hodgkin’s Lymphoma • Oncology • CD20
March 07, 2023
Study of 19(T2)28z1xx TRAC-Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Lymphoma
(clinicaltrials.gov)
- P1 | N=30 | Recruiting | Sponsor: Memorial Sloan Kettering Cancer Center
New P1 trial • Diffuse Large B Cell Lymphoma • Follicular Lymphoma • Hematological Malignancies • Non-Hodgkin’s Lymphoma • Oncology • CD20
1 to 3
Of
3
Go to page
1